US 6689560
Raf protein kinase therapeutics
expired A61KA61K38/00
Quick answer
US patent 6689560 (Raf protein kinase therapeutics) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00